Bone marrow transplantation for thalassaemia

Journal of Internal Medicine, Supplement

Volumn 242, Issue 740, 1997, Pages 49-52

  Lucarelli, G ^a  

^a NONE

Author keywords

Bone marrow transplantation; Thalassaemia

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; METHOTREXATE;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; BETA THALASSEMIA; CHILD; CONFERENCE PAPER; GENETIC DISORDER; HEPATOMEGALY; HLA TYPING; HUMAN; IRON CHELATION; LIVER FIBROSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE; THALASSEMIA; ALLOTRANSPLANTATION; ARTICLE; BONE MARROW TRANSPLANTATION; DISEASE FREE SURVIVAL; SURVIVAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; DISEASE-FREE SURVIVAL; HUMANS; SURVIVAL ANALYSIS; THALASSEMIA; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0030986526     PISSN: 09557873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (2)

1. Piomelli S. Loew T. Management of thalassemia major (Cooley's anemia). IlematolOncolClm North Am. 1991: 5: 557.
2. Thomas ED, Buckner CD, Sanders J, et al. Marrow transplantation for thalassemia. lancet 1982: DDS2:227.